Cargando…

Diuretic Resistance Treated with Low-Dose Hydralazine: A Case Report and Review of the Literature

We present a case of severe diuretic resistance and edema from acute cardiorenal syndrome complicating heart failure with preserved ejection fraction (HFpEF) and mild alcoholic liver disease. High doses of intravenous (iv) furosemide plus iv doses of chlorothiazide failed to increase the daily urine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshehri, Mohammed, Wilcox, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case and Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436697/ https://www.ncbi.nlm.nih.gov/pubmed/34595213 http://dx.doi.org/10.1159/000515387

Ejemplares similares

Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis
por: Holman, Sarah K., et al.
Publicado: (2017)

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

A Suspected Case of Hydralazine-Induced Hepatotoxicity: A Case Report and Review of Literature
por: Sharma, Munish, et al.
Publicado: (2018)

Hydralazine/unspecified calcium channel blocker: Lack of efficacy: case report
Publicado: (2022)

The Effect of Add-on Acetazolamide to Conventional Diuretics for Diuretic-resistant Edema Complicated with Hypercapnia: A Report of Two Cases
por: Inoue, Tomohiko, et al.
Publicado: (2021)

Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
por: Kramers, Bart J., et al.
Publicado: (2018)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review
por: Alawneh, Diala, et al.
Publicado: (2022)

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review
por: Doughem, Karim, et al.
Publicado: (2021)

Hydralazine: Vasculitis, diffuse alveolar haemorrhage and pauci-immune crescentic glomerulonephritis : case report
Publicado: (2020)

Hydralazine-Induced Vasculitis
por: Gandhi, Pulkit, et al.
Publicado: (2023)

Hydralazine-Induced Isolated Lupus Nephritis
por: Khan, Naseer, et al.
Publicado: (2020)

ANA-Negative Hydralazine-Induced Pericardial Effusion
por: Zeitjian, Vicken, et al.
Publicado: (2017)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

Hydralazine-Induced Lupus Presenting With Pancytopenia: A Case Report
por: Brar, Yudhveer, et al.
Publicado: (2022)

Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
por: Dueñas-Gonzalez, Alfonso, et al.
Publicado: (2010)

Anti-TNF-α and hydralazine drug-induced lupus
por: Quaresma, Maria Victória, et al.
Publicado: (2015)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
por: Khosla, Atulya Aman, et al.
Publicado: (2023)

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report
por: Al-Abdouh, Ahmad, et al.
Publicado: (2020)

Diuretics/nitroglycerin: Coronary steal syndrome: case report
Publicado: (2021)

Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease
por: Tampe, Björn, et al.
Publicado: (2014)

Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease
por: Larkin, Benjamin P., et al.
Publicado: (2022)

A Case of Cardiac Amyloidosis With Diuretic-Refractory Pleural Effusions Treated With Bevacizumab
por: Bae, Suk-Hyang, et al.
Publicado: (2010)

Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis
por: Novikov, Aleksey, et al.
Publicado: (2014)

Clinical Characteristics of Hydralazine-induced Lupus
por: Timlin, Homa, et al.
Publicado: (2019)

Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
por: Strubchevska, Kateryna, et al.
Publicado: (2023)

Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review
por: Abdulgayoom, Mohammed, et al.
Publicado: (2023)

Low doses of esmolol and phenylephrine act as diuretics during intravenous anesthesia
por: Li, Yu Hong, et al.
Publicado: (2012)

Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
por: Patel, Bimal V, et al.
Publicado: (2008)

Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet
por: Larkin, Benjamin P., et al.
Publicado: (2021)

A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage
por: Xue, Angela, et al.
Publicado: (2023)

Low-dose clozapine-related seizure: A case report and literature review
por: Le, Dan-Sheng, et al.
Publicado: (2021)

Adhesive capsulitis following COVID-19 vaccination: a case report and review of literature
por: Alshehri, Mohammed, et al.
Publicado: (2023)

Anti-neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Secondary to Hydralazine: A Case Report
por: Abdullah, Ahmed, et al.
Publicado: (2022)

Unspecified loop diuretics/zirconium silicate: Lack of efficacy: case report
Publicado: (2021)

Cardiorenal syndrome: Resistant to diuretics, sensitive to ultraflitration
por: Aundhakar, Swati C., et al.
Publicado: (2012)

Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome
por: Solomon-Tsegaye, Theodros, et al.
Publicado: (2018)

A hydralazine-induced triumvirate: Lupus, cutaneous vasculitis, and cryptococcoid Sweet syndrome
por: Skaljic, Meliha, et al.
Publicado: (2019)

Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies
por: Kannan, Lakshmi, et al.
Publicado: (2023)

Hydralazine target: From blood vessels to the epigenome
por: Arce, Claudia, et al.
Publicado: (2006)

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
por: Bibby, M. C., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_3mecionpe400bndo5r5240q7sm